The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / EULAR 2014: Shorten Delay for Access to Rheumatologic Patient Care

EULAR 2014: Shorten Delay for Access to Rheumatologic Patient Care

September 1, 2014 • By Thomas R. Collins

  • Tweet
  • Email
Print-Friendly Version / Save PDF

The ACR/EULAR joint task force identified four steps that can involve delay: the gap between the first symptoms and the patient visiting a GP; the gap between the first visit to the GP and a referral to a rheumatologist; the gap between the referral and actually seeing a rheumatologist; and the gap between seeing the rheumatologist and starting disease-modifying antirheumatic drug therapy.1

You Might Also Like
  • EULAR 2014: Ultrasound Use Important for Rheumatology
  • EULAR 2012: Partnership Between Physician and Patient
  • EULAR 2014: Collaboration Among Rheumatology Groups Expected to Build
Explore This Issue
September 2014
Also By This Author
  • What’s New in Inflammatory Arthritis?

Community awareness programs are one way to shorten the time it takes for patients to seek medical help once they notice symptoms. Such programs include screening questionnaires and the “Rheuma Bus” that’s been used in Germany. In general, such programs aren’t very effective, Dr. Fautrel said. “You need to reach many, many people with only a few people at risk,” he said.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Options for reducing the time between a GP visit and referral to a rheumatologist include joint consultations between the GP and the specialist, and easy-to-use tools for GPs to decide whether to make a referral.

Joint consultations can be too time consuming to be worthwhile, although they have been done with some success in the United Kingdom. Referral tools, though, are useful.

Dr. Fautrel said joint consultations can be too time consuming to be worthwhile, although they have been done with some success in the United Kingdom. Referral tools, though, are useful, he said. They include assessing whether certain tasks with the hand are painful or making a referral if certain clinical signs are present.

Professional education programs also have proved effective, including France’s Acting Early campaign, an education effort done over the phone in which 1,500 GPs were trained in six months.

Early arthritis clinics—used in the U.S. and Europe—have not shown greater capture of arthritis patients than more traditional healthcare channels and might not be worth the expense and effort involved, Dr. Fautrel said.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

Development of triage procedures to quickly get patients to a rheumatologist can be very worthwhile, he said. A grading system in London, Ontario, Canada, that assigns a letter grade to patients based on the urgency with which they need treatment has proved effective, Dr. Fautrel said. And in Wales, a joint organization by four rheumatology departments has successfully channeled patients to the proper caregivers, speeding care and eliminating unnecessary referrals.

These kinds of approaches “should be implemented more and more largely,” Dr. Fautrel said.

Why Patients Wait

Karim Raza, BMBCh, PhD, professor of clinical rheumatology at the University of Birmingham in the United Kingdom, has studied why it is that patients wait so long before they see a GP about symptoms that could be an indication of a inflammatory arthritis. What he has found is that patients tend to wait to seek help until their symptoms “get really bad” or interfere with their normal activities, new symptoms arise or they feel they can no longer control the symptoms on their own.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Pages: 1 2 3 | Single Page

Filed Under: Meeting Reports, Practice Management, Quality Assurance/Improvement, Spondyloarthritis Tagged With: AC&R, access, American College of Rheumatology, Ankylosing Spondylitis, barrier, Collins, EULAR, International, Pain, patient care, Quality, Rheumatoid arthritis, rheumatologistIssue: September 2014

You Might Also Like:
  • EULAR 2014: Ultrasound Use Important for Rheumatology
  • EULAR 2012: Partnership Between Physician and Patient
  • EULAR 2014: Collaboration Among Rheumatology Groups Expected to Build
  • EULAR 2014: Research on Rheumatoid Arthritis, Spondyloarthritis

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)